✦ LIBER ✦

PMH34 COST-EFFECTIVENESS ANALYSIS OF RISPERIDONE LONG-ACTING INJECTION IN SCHIZOPHRENIA: 24-MONTH DATA FROM CZECH REPUBLIC

✍ Scribed by Skoupá, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH21 COST-EFFECTIVENESS-ANALYSIS OF RIS

✍ J Skoupá; V Cerna; T Doležl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH24 Cost of Long-Acting Risperidone In

✍ V. Omelyanovsky; M. Avxentyeva; O. Ivakhnenko; P. Khailov; F.M. Tsfasman; I. Kry 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH11 The Cost-Effectiveness of Risperid

✍ Li, H.; Ren, J.; Yu, X. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PMH11 RISPERIDONE LONG-ACTING INJECTION

✍ J Pecenak; I Turna; M Povey; A Lam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PMH12 TREATMENT OUTCOMES OF RISPERIDONE

✍ I Tuma; J Pecenak; M Povey; A Lam; Z Zhao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB